drugset / Trial / NCT00584376
Pregabalin (Lyrica) for the Treatment of Essential Tremor
RandomizedCrossoverTriple-blindTreatment
Summary
This will be a multi-site, prospective, double-blind, randomized, placebo-controlled, crossover trial conducted over 6 months to assess the effectiveness and safety of PGB to treat symptoms of ET.
Timeline
- Start
- 2007-12
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pregabalin | Small molecule | 225 mg | Oral |